Abattis Bioceuticals (ATTBF) Short Interest Ratio & Short Volume

Abattis Bioceuticals Short Interest Data

Current Short Volume
10,600 shares
Previous Short Volume
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$0.00
Short Interest Ratio / Days to Cover
0.0
Last Record Date
November 15, 2021
Today's Trading Volume
25,300 shares
Average Trading Volume
11,650 shares
Today's Volume Vs. Average
217%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Abattis Bioceuticals ?

Sign up to receive the latest short interest report for Abattis Bioceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ATTBF Short Interest Over Time

ATTBF Days to Cover Over Time

ATTBF Percentage of Float Shorted Over Time

Abattis Bioceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202110,600 shares $0.00 No ChangeN/A0 $0.00
8/13/202121,900 shares $302.22 No ChangeN/A0 $0.01
5/28/2021100 shares $1.38 -95.7%N/A0 $0.01
5/14/20212,300 shares $33.12 +475.0%N/A0 $0.01
4/30/2021400 shares $6.52 -97.3%N/A0 $0.02
4/15/202114,900 shares $286.08 +14,800.0%N/A0 $0.02
3/31/2021100 shares $2.50 No ChangeN/A0 $0.03
3/15/2021100 shares $2.25 -90.0%N/A0 $0.02
2/26/20211,000 shares $23.00 +900.0%N/A0 $0.02
2/12/2021100 shares $3.40 No ChangeN/A0 $0.03
1/29/2021100 shares $1.57 -98.9%N/A0 $0.02
1/15/202117,700 shares $230.10 +90.3%N/A0 $0.01
12/31/20209,300 shares $124.43 -47.5%N/A0 $0.01
12/15/202017,700 shares $261.96 +90.3%N/A0 $0.01
11/30/20209,300 shares $63.71 No ChangeN/A0 $0.01
8/14/20207,700 shares $54.67 -90.7%N/A0 $0.01
7/31/202083,100 shares $648.18 +1,788.6%N/A0.2 $0.01
7/15/20204,400 shares $35.20 -59.6%N/A0 $0.01
6/30/202010,900 shares $94.83 -65.5%N/A0 $0.01
6/15/202031,600 shares $312.84 +54.2%N/A0 $0.01
5/29/202020,500 shares $176.30 +365.9%N/A0 $0.01
5/15/20204,400 shares $31.24 No ChangeN/A0 $0.01
4/15/202065,700 shares $394.20 No ChangeN/A0.1 $0.01
2/28/202011,400 shares $95.76 +159.1%N/A0 $0.01
2/14/20204,400 shares $47.08 -84.6%N/A0 $0.01
1/31/202028,600 shares $380.38 -87.5%N/A0 $0.01
1/15/2020228,000 shares $3,420.00 No ChangeN/A0.1 $0.02

ATTBF Short Interest - Frequently Asked Questions

What is Abattis Bioceuticals' current short interest?

Short interest is the volume of Abattis Bioceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 10,600 shares of ATTBF short. Learn More on Abattis Bioceuticals' current short interest.

Is Abattis Bioceuticals' short interest increasing or decreasing?

Abattis Bioceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 10,600 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Kansas City Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Abattis Bioceuticals stock?

Short selling ATTBF is an investing strategy that aims to generate trading profit from Abattis Bioceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abattis Bioceuticals?

A short squeeze for Abattis Bioceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATTBF, which in turn drives the price of the stock up even further.

How often is Abattis Bioceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATTBF, twice per month. The most recent reporting period available is November, 15 2021.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:ATTBF) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners